Cargando…
Hip region muscular dystrophy and emergence of motor deficits in dysferlin‐deficient Bla/J mice
The identification of a dysferlin‐deficient animal model that accurately displays both the physiological and behavior aspects of human dysferlinopathy is critical for the evaluation of potential therapeutics. Disease progression in dysferlin‐deficient mice is relatively mild, compared to the debilit...
Autores principales: | Nagy, Nadia, Nonneman, Randal J., Llanga, Telmo, Dial, Catherine F., Riddick, Natallia V., Hampton, Tom, Moy, Sheryl S., Lehtimäki, Kimmo K., Ahtoniemi, Toni, Puoliväli, Jukka, Windish, Hillarie, Albrecht, Douglas, Richard, Isabelle, Hirsch, Matthew L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371557/ https://www.ncbi.nlm.nih.gov/pubmed/28320887 http://dx.doi.org/10.14814/phy2.13173 |
Ejemplares similares
-
Systemic Delivery of Dysferlin Overlap Vectors Provides Long-Term Gene Expression and Functional Improvement for Dysferlinopathy
por: Potter, Rachael A., et al.
Publicado: (2018) -
Muscular dystrophy with marked Dysferlin deficiency is consistently caused by primary dysferlin gene mutations
por: Cacciottolo, Mafalda, et al.
Publicado: (2011) -
Using a State-of-the-Art Toolbox to Evaluate Molecular and Functional Readouts of Antisense Oligonucleotide-Induced Exon Skipping in mdx Mice
por: Datson, Nicole A., et al.
Publicado: (2020) -
New aspects on patients affected by dysferlin deficient muscular dystrophy
por: Klinge, Lars, et al.
Publicado: (2009) -
Effects of rituximab in two patients with dysferlin-deficient muscular dystrophy
por: Lerario, Alberto, et al.
Publicado: (2010)